Presented by
Management Forum
Delve into the world of additional Risk Minimization Measures (aRMMs) and explore everything from the regulatory framework surrounding aRMMs to their impact on patient safety and healthcare outcomes.
This course delves into the world of additional Risk Minimisation Measures (aRMMs), providing a thorough understanding of their development, implementation and assessment. Participants will explore the regulatory framework surrounding aRMMs, learn how to design effective risk minimisation strategies and evaluate their impact on patient safety and healthcare outcomes. This course combines theoretical knowledge with practical insights, enabling attendees to enhance their skills in managing and monitoring aRMMs in their organisations.
This course is part of our Vigilance training course collection; for information on the basics of PhV, consider taking a look at our beginner-friendly Pharmacovigilance training course.
Alina Panourgia is an experienced QA/PV Auditor and Regulatory Affairs professional, with a career spanning various regions.
Alina started her career in SEA working at the manufacturing site leading Quality Control/Regulatory Affairs department. She still prepares companies for inspections and provides trainings.
Since relocating to the Middle East in 2015, Alina has worked as a freelancer, collaborating with UK, US and EU companies on PV projects. Additionally, Alina has overseen regulatory submissions and pharmacovigilance activities in the MENA, LATAM and CIS regions.
Alina is a frequent speaker at international forums, conferences and training programs, sharing her expertise on various topics in pharmacovigilance, regulatory affairs and quality improvements.
She has presented at GCC Regulatory Affairs/PV Summits, Drug Safety Symposiums and other significant industry events within MENA region.
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: